What does CUSIP 45254C101 represent in this 13F holders report?

CUSIP 45254C101 is the security identifier for IMNP - IMMUNE PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held IMNP - IMMUNE PHARMACEUTICALS INC - COM in Q3 2014?

8 institutional investors reported IMNP - IMMUNE PHARMACEUTICALS INC - COM for Q3 2014. Use the holders table for investor-level position and value details.

IMMUNE PHARMACEUTICALS INC - COM (IMNP)

CUSIP: 45254C101

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class: Equity / COM
Total 13F shares: 148,918
Share change: +148,918
Total reported value: $499,000
Price per share: $3.36
Number of holders: 8
Value change: +$499,000
Number of buys: 8

Quarterly Holders Quick Answers

What is CUSIP 45254C101?
CUSIP 45254C101 identifies IMNP - IMMUNE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2014
Previous quarter: Q2 2014

Recent filing periods for CUSIP 45254C101:

Q2 2017 Q1 2017 Q4 2016 Q3 2016 Q2 2016 Q1 2016 Q4 2015 Q3 2015

Institutional Holders of IMMUNE PHARMACEUTICALS INC - COM (IMNP) as of Q3 2014

As of 30 Sep 2014, IMMUNE PHARMACEUTICALS INC - COM (IMNP) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 148,918 shares. The largest 8 holders included Geduld E E, GOLDMAN SACHS GROUP INC, DEUTSCHE BANK AG\, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Pictet & Cie (Europe) SA, Spark Investment Management LLC, MORGAN STANLEY, and Tower Research Capital LLC. This page lists 8 institutional shareholders reporting positions in this security for the Q3 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.